Cargando…
The association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injury
BACKGROUND: Preclinical studies highlight the importance of endogenous cannabinoids (endocannabinoids; eCBs) in neurodegeneration. Yet, prior observational studies focused on limited outcome measures and assessed only few eCB compounds while largely ignoring the complexity of the eCB system. We exam...
Autores principales: | Vered, Shiraz, Beiser, Alexa S., Sulimani, Liron, Sznitman, Sharon, Gonzales, Mitzi M., Aparicio, Hugo J., DeCarli, Charles, Scott, Matthew R., Ghosh, Saptaparni, Lewitus, Gil M., Meiri, David, Seshadri, Sudha, Weinstein, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496329/ https://www.ncbi.nlm.nih.gov/pubmed/37700370 http://dx.doi.org/10.1186/s13195-023-01301-x |
Ejemplares similares
-
Association of Loneliness With 10-Year Dementia Risk and Early Markers of Vulnerability for Neurocognitive Decline
por: Salinas, Joel, et al.
Publicado: (2022) -
Identifying Blood Biomarkers for Dementia Using Machine Learning Methods in the Framingham Heart Study
por: Lin, Honghuang, et al.
Publicado: (2022) -
Secular Trends in Head Size and Cerebral Volumes In the Framingham Heart Study for Birth Years 1902–1985
por: DeCarli, Charles, et al.
Publicado: (2023) -
Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
por: Weinstein, Galit, et al.
Publicado: (2016) -
Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study
por: Romero, José Rafael, et al.
Publicado: (2020)